These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ]. Torp-Pedersen CT; Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171 [No Abstract] [Full Text] [Related]
3. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure? Doggrell SA Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448 [TBL] [Abstract][Full Text] [Related]
4. Commentary on the Carvedilol or Metoprolol European Trial (COMET). Poole-Wilson PA Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936 [TBL] [Abstract][Full Text] [Related]
5. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol]. Swedberg K Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169 [No Abstract] [Full Text] [Related]
7. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study]. Ertl G; Nitschmann S Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581 [No Abstract] [Full Text] [Related]
8. Carvedilol and metoprolol European trial: do the results merit challenge? Smith KM Am J Health Syst Pharm; 2004 Jun; 61(12):1289-93. PubMed ID: 15259762 [No Abstract] [Full Text] [Related]
9. Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary). Rajput FS; Gnanasekeram H; Satwani S; Davenport JD; Gracely EJ; Gopalan R; Narula J Am J Cardiol; 2003 Jul; 92(2):218-21. PubMed ID: 12860230 [No Abstract] [Full Text] [Related]
10. [A fairer comparison between carvedilol and metoprolol is still to be done]. Johnsson G; Aberg J Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018 [No Abstract] [Full Text] [Related]
11. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET. Cleland JG Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030 [TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. Poole-Wilson PA; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Metra M; J Remme W; Swedberg K; Torp-Pedersen C Eur J Heart Fail; 2002 Jun; 4(3):321-9. PubMed ID: 12034158 [TBL] [Abstract][Full Text] [Related]
14. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173 [TBL] [Abstract][Full Text] [Related]
15. The carvedilol or metoprolol European trial. Meyer TE Curr Cardiol Rep; 2004 May; 6(3):198-9. PubMed ID: 15075055 [No Abstract] [Full Text] [Related]
16. In heart failure, all beta-blockers are not necessarily equal. Tang WH; Militello M; Francis GS Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687 [TBL] [Abstract][Full Text] [Related]
18. A comment on COMET: how to interpret a positive trial? Massie BM J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781 [No Abstract] [Full Text] [Related]
19. Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial. Packer M J Card Fail; 2003 Dec; 9(6):429-43. PubMed ID: 14966782 [TBL] [Abstract][Full Text] [Related]
20. A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial. Shepherd AM J Card Fail; 2003 Dec; 9(6):454-7. PubMed ID: 14966784 [No Abstract] [Full Text] [Related] [Next] [New Search]